Top news of the week: 26.10.2022.
Mereo Issues Guidance to Shareholders Ahead of November Leadership Vote
The proxy battle between Mereo BioPharma and Rubric Capital Management will come to a head on Nov. 18. Mereo issued a shareholder circular on Friday.
Biospace Movers & Shakers: Maravai, Predictive Oncology, Exagen and More Tap New Execs
With the appointment of new CEOs, CMOs and CSOs, biopharma and life sciences organizations shuffled their leadership positions as Q3 comes to a close.
Scholar Rock Continues to Build Case for SMA Drug with New Data
New data from Scholar Rock’s Phase II TOPAZ trial showed its investigational antibody apitegromab improves quality of life in types 2 and 3 spinal muscular atrophy patients.
Become A Sponsor
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services.
Sumitomo ups ante and wins support for Myovant takeover
A sweetened offer from Sumitomo Pharma has convinced endocrinology specialist Myovant to agree to a takeover, after its first was rejected.
The RPM Report
Get expert coverage of drug developments and global policy and regulatory changes across the industry. Daily insight and analysis of commercial developments impacting the …
OSE On The Up As Phase III For Cancer Vaccine Is Prepped
OSE’s late-stage ambitions for Tedopi were stalled by the pandemic but the Nantes-based firm has now requested a meeting with the US FDA to get the Phase III program for the anticancer ...
Syngene climbs over 8% after better than expected September quarter
Shares of Syngene International climbed over 7 percent after the company reported a 53 percent rise in consolidated net profit at Rs 102 crore as compared to standing at Rs 66.7 crore in ...